These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 28673246

  • 1. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a meta-analysis.
    Feng AF, Liu ZH, Zhou SL, Zhao SY, Zhu YX, Wang HX.
    BMC Cardiovasc Disord; 2017 Jul 03; 17(1):174. PubMed ID: 28673246
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP, Palmer BR, Pilbrow AP, Frampton CM, Troughton RW, Yandle TG, Skelton L, Richards AM, Cameron VA.
    Am Heart J; 2006 Aug 03; 152(2):312-20. PubMed ID: 16875916
    [Abstract] [Full Text] [Related]

  • 3. Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients.
    Nemati R, Lu J, Ramachandran V, Etemad A, Heidari M, Yahya MJ, Roozafzoon R, Ismail P.
    Genet Mol Res; 2016 Jun 20; 15(2):. PubMed ID: 27323204
    [Abstract] [Full Text] [Related]

  • 4. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
    Safranow K, Czyzycka E, Binczak-Kuleta A, Rzeuski R, Skowronek J, Wojtarowicz A, Jakubowska K, Olszewska M, Loniewska B, Kaliszczak R, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D.
    Scand J Clin Lab Invest; 2009 Jun 20; 69(1):102-12. PubMed ID: 18855224
    [Abstract] [Full Text] [Related]

  • 5. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P, Lamblin N, Helbecque N, Mouquet F, Hermant X, Amouyel P, Dallongeville J, Bauters C.
    Am Heart J; 2006 Oct 20; 152(4):736-41. PubMed ID: 16996850
    [Abstract] [Full Text] [Related]

  • 6. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
    Safranow K, Suchy J, Jakubowska K, Olszewska M, Bińczak-Kuleta A, Kurzawski G, Rzeuski R, Czyżycka E, Łoniewska B, Kornacewicz-Jach Z, Ciechanowicz A, Chlubek D.
    J Appl Genet; 2011 Feb 20; 52(1):67-76. PubMed ID: 21108053
    [Abstract] [Full Text] [Related]

  • 7. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Kalsi KK, Yuen AH, Rybakowska IM, Johnson PH, Slominska E, Birks EJ, Kaletha K, Yacoub MH, Smolenski RT.
    Cardiovasc Res; 2003 Sep 01; 59(3):678-84. PubMed ID: 14499869
    [Abstract] [Full Text] [Related]

  • 8. AMPD1 C34T Polymorphism (rs17602729) Is Not Associated with Post-Exercise Changes of Body Weight, Body Composition, and Biochemical Parameters in Caucasian Females.
    Leońska-Duniec A, Maculewicz E, Humińska-Lisowska K, Maciejewska-Skrendo A, Leźnicka K, Cięszczyk P, Sawczuk M, Trybek G, Wilk M, Lepionka W, Ficek K.
    Genes (Basel); 2020 May 16; 11(5):. PubMed ID: 32429460
    [Abstract] [Full Text] [Related]

  • 9. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study.
    Rico-Sanz J, Rankinen T, Joanisse DR, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C, HERITAGE Family study.
    Physiol Genomics; 2003 Jul 07; 14(2):161-6. PubMed ID: 12783984
    [Abstract] [Full Text] [Related]

  • 10. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB, Breen JB, Rogers P, Johnson PH, Smith J, Smolenski RT, Banner NR, Yacoub MH, Barton PJ.
    Am J Cardiol; 2009 May 15; 103(10):1457-62. PubMed ID: 19427446
    [Abstract] [Full Text] [Related]

  • 11. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes.
    Ginevičienė V, Jakaitienė A, Pranculis A, Milašius K, Tubelis L, Utkus A.
    BMC Genet; 2014 May 17; 15():58. PubMed ID: 24885427
    [Abstract] [Full Text] [Related]

  • 12. A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
    Yazaki Y, Muhlestein JB, Carlquist JF, Bair TL, Horne BD, Renlund DG, Anderson JL.
    J Card Fail; 2004 Aug 17; 10(4):316-20. PubMed ID: 15309698
    [Abstract] [Full Text] [Related]

  • 13. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG, Botto N, Laghi-Pasini F, Manfredi S, Ghelarducci B, Farneti A, Solinas M, Biagini A, Picano E.
    Int J Cardiol; 2005 May 25; 101(2):191-5. PubMed ID: 15882662
    [Abstract] [Full Text] [Related]

  • 14. AMPD1 gene polymorphism and the vasodilatory response to ischemia.
    Hand BD, Roth SM, Roltsch MH, Park JJ, Kostek MC, Ferrell RE, Brown MD.
    Life Sci; 2006 Sep 05; 79(15):1413-8. PubMed ID: 16707139
    [Abstract] [Full Text] [Related]

  • 15. Association between AMPD1 gene polymorphism and coagulation factors in patients with coronary heart disease.
    Agewall S, Norman B.
    Pathophysiol Haemost Thromb; 2006 Sep 05; 35(6):440-4. PubMed ID: 17565237
    [Abstract] [Full Text] [Related]

  • 16. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
    Kalsi KK, Yuen AH, Johnson PH, Birks EJ, Yacoub MH, Smolenski RT.
    Nucleosides Nucleotides Nucleic Acids; 2005 Sep 05; 24(4):287-8. PubMed ID: 16021918
    [Abstract] [Full Text] [Related]

  • 17. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
    Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N.
    J Am Coll Cardiol; 2000 Oct 05; 36(4):1248-52. PubMed ID: 11028479
    [Abstract] [Full Text] [Related]

  • 18. Effect of creatine supplementation on physical performance are related to the AMPD1 and PPARG genes polymorphisms in football players.
    Lifanov D, Khadyeva MN, Rahmatullina LSh, Demenev SV, Ibragimov RR.
    Ross Fiziol Zh Im I M Sechenova; 2014 Jun 05; 100(6):767-76. PubMed ID: 25665401
    [Abstract] [Full Text] [Related]

  • 19. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ, Carlquist JF, Thaneemit-Chen S, Lazzeroni LC, Whiting BM, Horne BD, Muhlestein JB, Lavori P, Anderson JL.
    J Card Fail; 2005 Dec 05; 11(9):677-83. PubMed ID: 16360962
    [Abstract] [Full Text] [Related]

  • 20. C34T AMP deaminase 1 gene mutation protects cardiac function in donors.
    Yacoub MH, Yuen AH, Kalsi KK, Birks EJ, Taegtmeyer A, Barton PJ, Johnson PH, Suzuki K, Smolenski RT.
    Transplantation; 2004 May 27; 77(10):1621-3. PubMed ID: 15239633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.